It is a pharma private limited company based in New Delhi, Delhi, India, established in 2015.
2015 | New Delhi, Delhi, India | ActiveExcellent Formulations Private Limited, a active private limited company, was established on 09 February 2015 in New Delhi, Delhi, India. Engaging in pharmaceutical retailers & distributors within the hospital and medical care sector, it holds CIN: U52311DL2015PTC276484. Registered under ROC Roc Delhi. it is unlisted. It has an authorized capital of ₹0.10 M and a paid-up capital of ₹0.10 M.
It upholds a compliant status. Its leadership includes Arshad Ali (Director), Shoyab Ali (Director), Nisha Ali (Director). Past directors included Rakesh Sinha, Meeta Sinha, Binay Kumar. Its latest AGM occurred on 15 September 2025, with the balance sheet filed on 31 March 2025. It is based at No 4B, Kh. No. 11/11, & 11/20, Qutub Vihar, Phase-1, Main Jhankar Road, New Delhi, Delhi, 110071.
U52311DL2015PTC276484
276484
09 February 2015
₹0.10 M
₹0.10 M
Roc Delhi
Unlisted
Active
Explore comprehensive insights into Excellent Formulations Private Limited — covering financial performance, compliance records, Competitor, shareholding patterns, directors, key metrics, and litigation history. Unlock to see detailed insights and stay informed.
Access Report
| Name | Designation | Appointment Date | Status |
|---|---|---|---|
| Arshad Ali | Director | 02 May 2019 | Current |
| Shoyab Ali | Director | 02 May 2019 | Current |
| Nisha Ali | Director | 02 May 2019 | Current |
| Name | Designation | Cessation | Status |
|---|---|---|---|
| Pramod Abcsdd | Director | 26 Mar 2019 | Past |
| Pramod Abcsdd | Director | 26 Mar 2019 | Past |
| Pramod Abcsdd | Director | 26 Mar 2019 | Past |
| Pramod Abcsdd | Director | 26 Mar 2019 | Past |
| Pramod Abcsdd | Director | 07 May 2019 | Past |
| Pramod Abcsdd | Director | 07 May 2019 | Past |
Discover detailed profiles of directors and KMP - Unlock leadership insights today!
Excellent Formulations Private Limited, for the financial year ended 2018, experienced no change in revenue, with a 0% increase. The company also saw a slight decrease in profitability, with a 1.29% decrease in profit. The company's net worth observed a substantial decline by a decrease of 24.82%.
| Metrics |
| (FY 2022) | (FY 2021) | (FY 2020) | (FY 2019) | ||
|---|---|---|---|---|---|---|---|
| Total Revenue | |||||||
| Revenue from Operations | |||||||
| Total Assets |
| ||||||
| Profit or Loss |
| ||||||
| Net Worth |
| ||||||
| EBITDA |
|
In 2018, Excellent Formulations had a promoter holding of 100.00%. Access key insights, ownership, including shareholding patterns, funding, foreign investors, KMP remuneration, group structure, and overseas investments.
Reveal ownership structures and financial performance - Get instant access now!
There are no open charges registered against the company as per our records.
Unlock and access historical data on people associated with Excellent Formulations, such as employment history, contributions to the Employees' Provident Fund Organization (EPFO), and related information.
Gain comprehensive insights into the Deals and Valuation data of Excellent Formulations, offering detailed information on various transactions, including security allotment data. Explore the intricate details of financial agreements, mergers, acquisitions, divestitures, and strategic partnerships that have shaped Excellent Formulations's trajectory.
Access the credit rating data, providing valuable insights into the company's creditworthiness and financial stability. Explore assessments from leading credit rating agencies, evaluating factors such as debt obligations, liquidity, profitability, and overall financial health.
Stay informed about regulatory alerts and litigation involving and associated companies. Receive timely updates on legal proceedings, regulatory changes, and compliance issues that may impact the company's operations, reputation, and financial performance. Monitor litigation involving subsidiaries, joint ventures, and other affiliated entities to assess potential risks and liabilities.
The activity Excellent Formulations Private Limited last Annual general meeting of members was held on 15 Sep 2025 as per latest MCA records. was completed.
Excellent Formulations Private Limited has filed its annual Financial statements for the year ended 31 Mar 2025 with Roc Delhi. was recorded as a recent event.
Progress on Arshad Ali was appointed as a Director was appointed as a Director on 02 May 2019 & has been associated with this company since 6 years 8 months . was documented.
The activity Shoyab Ali was appointed as a Director was appointed as a Director on 02 May 2019 & has been associated with this company since 6 years 8 months . was completed.
The activity Nisha Ali was appointed as a Director was appointed as a Director on 02 May 2019 & has been associated with this company since 6 years 8 months . was completed.
The activity Excellent Formulations Private Limited was registered on 09 Feb 2015 with Roc Delhi & aged 10 years 11 months as per MCA records. was completed.
The CIN of Excellent Formulations Private Limited is U52311DL2015PTC276484.
Excellent Formulations Private Limited is headquartered at No 4B, Kh. No. 11/11, & 11/20, Qutub Vihar, Phase-1, Main Jhankar Road, New Delhi, Delhi, 110071.
Excellent Formulations Private Limited was incorporated on 09 February 2015.
The current directors of Excellent Formulations Private Limited are
The primary industry of Excellent Formulations Private Limited is Hospital And Medical Care.
Excellent Formulations Private Limited is unlisted.
The authorized capital of Excellent Formulations Private Limited is ₹0.10 M, and the paid-up capital is ₹0.10 M.
The compliance status of Excellent Formulations Private Limited is Compliant.
Search company & director profiles for free and gain access to critical business data.
Company Details
+91-XXXXXXXXXX